Factors influencing the statistical power of complex data analysis protocols for molecular signature development from microarray data

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Aliferis, Constantin F ^a,b,c   Statnikov, Alexander ^b   Tsamardinos, Ioannis ^b,d   Schildcrout, Jonathan S ^c   Shepherd, Bryan E ^c   Harrell Jr , Frank E ^c  

^a NEW YORK UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER SURVIVAL; DATA ANALYSIS; DNA MICROARRAY; GENE EXPRESSION; HUMAN; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; MEDULLOBLASTOMA; MOLECULAR GENETICS; NONHODGKIN LYMPHOMA; RECEIVER OPERATING CHARACTERISTIC; SIMULATION; STATISTICAL ANALYSIS; GENETICS; NEOPLASM;

DATA INTERPRETATION, STATISTICAL; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 62849087796     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004922     Document Type: Article

References (50)

1. Butte A (2002) The use and analysis of microarray data. Nat Rev Drug Discov 1: 951-960.
2. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
3. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, et al. (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98: 15149-15154.
4. Dupuy A, Simon RM (2007) Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 99: 147-157.
5. Potti A, Dressman HK, Bild A, Riedel RF, Chan G, et al. (2006) Genomic signatures to guide the use of chemotherapeutics. Nat Med 12: 1294-1300.
6. Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, et al. (1998) Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 4: 1293-1301.
7. Burczynski ME, Peterson RL, Twine NC, Zuberek KA, Brodeur BJ, et al. (2006) Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J Mol Diagn 8: 51-61.
8. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, et al. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1: 133-143.
9. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
10. Bammler T, Beyer RP, Bhattacharya S, Boorman GA, Boyles A, et al. (2005) Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2: 351-356.
11. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, et al. (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24: 1151-1161.
12. Mukherjee S, Golland P, Panchenko D (2003) Permutation tests for classification. MIT AI Memo, 2003-019.
13. Radmacher MD, McShane LM, Simon R (2002) A paradigm for class prediction using gene expression profiles. J Comput Biol 9: 505-511.
14. Good PI (2000) Permutation tests: a practical guide to resampling methods for testing hypotheses. New York: Springer.
15. Lehmann EL, Stein C (1949) On the Theory of Some Non-Parametric Hypotheses. The Annals of Mathematical Statistics 20: 28-45.
16. Lee ML, Whitmore GA (2002) Power and sample size for DNA microarray studies. Stat Med 21: 3543-3570.
17. Baldi P, Hatfield GW (2002) DNA microarrays and gene expression. Cambridge, UK: Cambridge University Press.
18. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8: 816-824.
19. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, et al. (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98: 13790-13795.
20. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947.
21. Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, et al. (2003) Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 361: 923-929.
22. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, et al. (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415: 436-442.
23. Michiels S, Koscielny S, Hill C (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365: 488-492.
24. Glas AM, Floore A, Delahaye LJ, Witteveen AT, Pover RC, et al. (2006) Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7: 278.
25. Ein-Dor L, Zuk O, Domany E (2006) Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci U S A 103: 5923-5928.
26. Ioannidis JP (2005) Microarrays and molecular research: noise discovery? Lancet 365: 454-455.
27. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387.
28. Freidlin B, Gastwirth JL (2000) Should the Median Test be Retired from General Use? The American Statistician 54: 161-164.
29. Ling CX, Huang J, Zhang H (2003) AUC: a statistically consistent and more discriminating measure than accuracy. Proceedings of the Eighteenth International Joint Conference of Artificial Intelligence (IJCAI).
30. Hastie T, Tibshirani R, Friedman JH (2001) The elements of statistical learning: data mining, inference, and prediction. New York: Springer.
31. Statnikov A, Aliferis CF, Tsamardinos I, Hardin D, Levy S (2005) A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis. Bioinformatics 21: 631-643.
32. Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, et al. (2000) Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 16: 906-914.
33. Statnikov A, Wang L, Aliferis CF (2008) A comprehensive comparison of random forests and support vector machines for microarray-based cancer classification. BMC Bioinformatics 9: 319.
34. Kohavi R (1995) A study of cross-validation and bootstrap for accuracy estimation and model selection. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence (IJCAI) 2: 1137-1145.
35. Casella G, Berger RL (2002) Statistical inference. Australia: Thomson Learning.
36. Braga-Neto UM, Dougherty ER (2004) Is cross-validation valid for small-sample microarray classification? Bioinformatics 20: 374-380.
37. Saerens M, Latinne P, Decaestecker C (2001) Adjusting the Outputs of a Classifier to New a Priori Probabilities: A Simple Procedure. Neural Computation 14: 21-41.
38. Jiang W, Simon R (2007) A comparison of bootstrap methods and an adjusted bootstrap approach for estimating the prediction error in microarray classification. Stat Med 26: 5320-5334.
39. Habel LA, Shak S, Jacobs MK, Capra A, Alexander C, et al. (2006) A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res 8: R25.
40. Paik S, Shak S, Tang G, Kim C, Baker J, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826.
41. Paik S, Tang G, Shak S, Kim C, Baker J, et al. (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24: 3726-3734.
42. Sparano JA, Paik S (2008) Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol 26: 721-728.
43. Statnikov A, Tsamardinos I, Dosbayev Y, Aliferis CF (2005) GEMS: a system for automated cancer diagnosis and biomarker discovery from microarray gene expression data. Int J Med Inform 74: 491-503.
44. Dobbin KK, Zhao Y, Simon RM (2008) How large a training set is needed to develop a classifier for microarray data? Clin Cancer Res 14: 108-114.
45. Dobbin KK, Simon RM (2007) Sample size planning for developing classifiers using high-dimensional DNA microarray data. Biostatistics 8: 101-117.
46. Hand DJ, Till RJ (2001) A simple generalisation of the area under the ROC curve for multiple class classification problems. Machine Learning 45: 171-186.
47. Simon R (2003) Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br J Cancer 89: 1599-1604.
48. Fan RE, Chen PH, Lin CJ (2005) Working set selection using second order information for training support vector machines. Journal of Machine Learning Research 6: 1918.
49. Vapnik VN (1998) Statistical learning theory. New York: Wiley.
50. Aliferis CF, Statnikov A, Tsamardinos I (2006) Challenges in the analysis of mass-throughput data: a technical commentary from the statistical machine learning perspective. Cancer Informatics 2: 133-162.